Microbiotix, Inc.
Microbiotix, Inc. is a clinical stage biopharmaceutical company dedicated to the discovery and development of proprietary small molecule drugs targeting serious infectious diseases, including multi-drug resistant pathogens. The company is recognized for its innovation and has consistently been a top recipient of NIH awards among Massachusetts biotech/pharma companies.
Microbiotix, Inc.
One Innovation Drive, Worcester, MA 01605
What We Do
A potent and novel nucleoside analog dual DNA polymerase/kinase inhibitor for the treatment of human cytomegalovirus (CMV). MBX-400 has successfully completed Phase 1 clinical testing.
Infectious Diseases
Show LessKey People
President & CEO
Chief Business Officer
News & Updates
Microbiotix has consistently been the top recipient of NIH awards amongst Massachusetts biotech/pharma companies.